InsiderGauge
Checking updates…
Dashboard

FTHFaeth Therapeutics, Inc.

Market cap
$441.35M
as of 2026-10-23
Latest close
$17.08
as of 2026-10-23
Sector
Healthcare
as of 2026-10-24
Industry
Biotechnology
as of 2026-10-24

Cluster

No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).

Form 4 historysince 2023-11-02

Dashed line = amended filing (Form 4/A)

InsiderTradedFiledTypeSharesPriceValueOwned after10b5-1 planFiling
Vousden Karen HSep 11Sep 15A · derivative25,000$37.44$936,00025,000NoForm 4
Craver JosiahPAOJul 21Jul 23A · derivative30,824$28.37$874,47730,824NoForm 4
Parikh Anand KiranPresident and CEOJul 21Jul 23A · derivative398,018$28.37$11,291,771398,018NoForm 4
Stephenson Brian CChief Financial OfficerJul 1Jul 1P4,400$23.40Purchase +$102,96046,088NoForm 4
Stephenson Brian CChief Financial OfficerJul 1Jul 1P600$24.22Purchase +$14,53246,688NoForm 4
Stephenson Brian CChief Financial OfficerJun 30Jul 1P1,910$22.95Purchase +$43,83535,795NoForm 4
Stephenson Brian CChief Financial OfficerJun 30Jul 1P1,638$23.88Purchase +$39,11537,433NoForm 4
Stephenson Brian CChief Financial OfficerJun 30Jul 1P4,255$24.98Purchase +$106,29041,688NoForm 4
Stephenson Brian CChief Financial OfficerJun 29Jul 1P831$23.34Purchase +$19,39633,885NoForm 4
Stephenson Brian CChief Financial OfficerJun 26Jun 26P580$23.61Purchase +$13,69427,384NoForm 4
Stephenson Brian CChief Financial OfficerJun 26Jun 26P4,212$24.90Purchase +$104,87931,596NoForm 4
Stephenson Brian CChief Financial OfficerJun 26Jun 26P1,358$25.55Purchase +$34,69732,954NoForm 4
Stephenson Brian CChief Financial OfficerJun 26Jun 26P100$26.39Purchase +$2,63933,054NoForm 4
Stephenson Brian CChief Financial OfficerJun 24Jun 26P2,891$25.22Purchase +$72,91120,304NoForm 4
Stephenson Brian CChief Financial OfficerJun 24Jun 26P3,000$25.98Purchase +$77,94023,304NoForm 4
Stephenson Brian CChief Financial OfficerJun 24Jun 26P3,400$26.98Purchase +$91,73226,704NoForm 4
Stephenson Brian CChief Financial OfficerJun 24Jun 26P100$27.77Purchase +$2,77726,804NoForm 4
Stephenson Brian CChief Financial OfficerJun 23Jun 24P6,836$24.12Purchase +$164,88415,019NoForm 4
Stephenson Brian CChief Financial OfficerJun 23Jun 24P1,969$24.84Purchase +$48,91016,988NoForm 4
Stephenson Brian CChief Financial OfficerJun 23Jun 24P425$25.91Purchase +$11,01217,413NoForm 4
Stephenson Brian CChief Financial OfficerJun 22Jun 24P1,797$20.23Purchase +$36,3531,797NoForm 4
Stephenson Brian CChief Financial OfficerJun 22Jun 24P1,118$20.82Purchase +$23,2772,915NoForm 4
Stephenson Brian CChief Financial OfficerJun 22Jun 24P1,583$22.40Purchase +$35,4594,498NoForm 4
Stephenson Brian CChief Financial OfficerJun 22Jun 24P3,329$23.28Purchase +$77,4997,827NoForm 4
Stephenson Brian CChief Financial OfficerJun 22Jun 24P356$23.95Purchase +$8,5268,183NoForm 4
Parikh Anand KiranPresident and CEOJun 22Jun 24P2,806$19.76Purchase +$55,447764,234NoForm 4
Parikh Anand KiranPresident and CEOJun 22Jun 24M45,252$1.16$52,492809,486NoForm 4
Parikh Anand KiranPresident and CEOJun 22Jun 24M8,213$1.16$9,527817,699NoForm 4
Parikh Anand KiranPresident and CEOJun 22Jun 24M · derivative45,252$1.16$52,49291,632NoForm 4
Parikh Anand KiranPresident and CEOJun 22Jun 24M · derivative8,213$1.16$9,5274,107NoForm 4
Parikh Anand KiranPresident and CEOJun 15Jun 16C761,428not reportednot reported761,428NoForm 4
Parikh Anand KiranPresident and CEOJun 15Jun 16C · derivative761.43not reportednot reportednot reportedNoForm 4
Hahn Stephen M.Jun 15Jun 16C44,763not reportednot reported44,763NoForm 4
Hahn Stephen M.Jun 15Jun 16C · derivative44.76not reportednot reportednot reportedNoForm 4
Ramasastry SairaJun 12Jun 16A · derivative25,000$13.00$325,00025,000NoForm 4
Hahn Stephen M.Jun 12Jun 16A · derivative25,000$13.00$325,00025,000NoForm 4
Parikh Anand KiranPresident and CEOFeb 17Jun 164/AA · derivative761.43not reportednot reported761,428NoForm 4/A
Parikh Anand KiranPresident and CEOFeb 17Jun 164/AA · derivative12,320$1.16$14,29112,320NoForm 4/A
Parikh Anand KiranPresident and CEOFeb 17Jun 164/AA · derivative136,884$1.16$158,785136,884NoForm 4/A
Donenberg Phillip B.Jun 10Jun 12A · derivative12,500$11.41$142,62512,500NoForm 4
Holmen BobJun 10Jun 12A · derivative12,500$11.41$142,62512,500NoForm 4
Gerry ChristopherPresident & PEOJun 10Jun 12A · derivative220,000$29.89$6,575,800220,000NoForm 4
Peyer JamesJun 1Jun 1S24,524$20.00Sale −$490,480130,618NoForm 4
Peyer JamesJun 1Jun 1S476$21.14Sale −$10,063130,142NoForm 4
Cambrian BioPharma IncJun 1Jun 1S24,524$20.00Sale −$490,480130,618NoForm 4
Cambrian BioPharma IncJun 1Jun 1S476$21.14Sale −$10,063130,142NoForm 4
Ics Opportunities II LLCApr 7May 15P1,108$33.38Purchase +$36,985133,986NoForm 4
Ics Opportunities II LLCApr 7May 15S2,115$28.94Sale −$61,208133,986NoForm 4
Ics Opportunities II LLCApr 7May 15S205$29.71Sale −$6,091133,986NoForm 4
Ics Opportunities II LLCApr 7May 15S4,423$31.38Sale −$138,794133,986NoForm 4
Ics Opportunities II LLCApr 7May 15S300$32.25Sale −$9,675133,986NoForm 4
Ics Opportunities II LLCApr 7May 15S1,108$33.38Sale −$36,985133,986NoForm 4
Ics Opportunities II LLCApr 6May 15P1,104$31.02Purchase +$34,246141,029NoForm 4
Ics Opportunities II LLCApr 6May 15S1,214$31.02Sale −$37,658141,029NoForm 4
Ics Opportunities II LLCApr 6May 15S45$31.96Sale −$1,438141,029NoForm 4
Ics Opportunities II LLCApr 2May 15P26$33.47Purchase +$870144,974NoForm 4
Ics Opportunities II LLCApr 2May 15P1,276$34.75Purchase +$44,341144,974NoForm 4
Ics Opportunities II LLCApr 2May 15P701$35.55Purchase +$24,921144,974NoForm 4
Ics Opportunities II LLCApr 2May 15S3,099$30.86Sale −$95,635144,974NoForm 4
Ics Opportunities II LLCApr 2May 15S1,265$31.75Sale −$40,164144,974NoForm 4
Ics Opportunities II LLCApr 2May 15S1,794$32.60Sale −$58,484144,974NoForm 4
Ics Opportunities II LLCApr 2May 15S374$33.35Sale −$12,473144,974NoForm 4
Ics Opportunities II LLCApr 2May 15S1,134$34.80Sale −$39,463144,974NoForm 4
Millennium Management LLCApr 1May 15P1,161$31.53Purchase +$36,606147,731NoForm 4
Millennium Management LLCApr 1May 15P1,613$34.59Purchase +$55,794147,731NoForm 4
Millennium Management LLCApr 1May 15P3,401$35.46Purchase +$120,599147,731NoForm 4
Millennium Management LLCApr 1May 15S1,104$31.52Sale −$34,798147,731NoForm 4
Millennium Management LLCApr 1May 15S46$34.75Sale −$1,599147,731NoForm 4
Millennium Management LLCMar 31May 15P616$24.69Purchase +$15,209146,657NoForm 4
Millennium Management LLCMar 31May 15P1,770$25.32Purchase +$44,816146,657NoForm 4
Millennium Management LLCMar 31May 15P1,048$26.73Purchase +$28,013146,657NoForm 4
Millennium Management LLCMar 31May 15P17$27.78Purchase +$472146,657NoForm 4
Millennium Management LLCMar 31May 15P186$30.48Purchase +$5,669146,657NoForm 4
Millennium Management LLCMar 31May 15P1,957$31.45Purchase +$61,548146,657NoForm 4
Millennium Management LLCMar 31May 15P411$32.60Purchase +$13,399146,657NoForm 4
Millennium Management LLCMar 31May 15S191$24.28Sale −$4,637146,657NoForm 4
Millennium Management LLCMar 31May 15S1,251$25.17Sale −$31,488146,657NoForm 4
Millennium Management LLCMar 31May 15S57$27.11Sale −$1,545146,657NoForm 4
Millennium Management LLCMar 31May 15S5$28.41Sale −$142146,657NoForm 4
Millennium Management LLCMar 31May 15S87$31.52Sale −$2,742146,657NoForm 4
Ics Opportunities II LLCMar 30May 15P2,992$25.08Purchase +$75,039145,678NoForm 4
Ics Opportunities II LLCMar 30May 15P4,995$25.99Purchase +$129,820145,678NoForm 4
Ics Opportunities II LLCMar 30May 15P1,176$26.70Purchase +$31,399145,678NoForm 4
Ics Opportunities II LLCMar 30May 15P370$27.68Purchase +$10,242145,678NoForm 4
Ics Opportunities II LLCMar 30May 15S518$25.85Sale −$13,390145,678NoForm 4
Ics Opportunities II LLCMar 30May 15S370$27.68Sale −$10,242145,678NoForm 4
Ics Opportunities II LLCMar 27May 15P10,643$26.29Purchase +$279,804142,360NoForm 4
Ics Opportunities II LLCMar 27May 15P4,384$27.28Purchase +$119,596142,360NoForm 4
Ics Opportunities II LLCMar 27May 15P294$28.13Purchase +$8,270142,360NoForm 4
Ics Opportunities II LLCMar 27May 15S469$26.77Sale −$12,555142,360NoForm 4
Ics Opportunities II LLCMar 27May 15S36$27.37Sale −$985142,360NoForm 4
Ics Opportunities II LLCMar 26May 15P778$27.23Purchase +$21,185131,370NoForm 4
Ics Opportunities II LLCMar 26May 15P1,327$27.95Purchase +$37,090131,370NoForm 4
Ics Opportunities II LLCMar 26May 15P2,601$28.85Purchase +$75,039131,370NoForm 4
Ics Opportunities II LLCMar 26May 15P1,025$29.98Purchase +$30,730131,370NoForm 4
Ics Opportunities II LLCMar 26May 15S583$26.88Sale −$15,671131,370NoForm 4
Ics Opportunities II LLCMar 26May 15S1,274$28.69Sale −$36,551131,370NoForm 4
Donenberg Phillip B.Apr 10Apr 14A · derivative23,100$29.89$690,45923,100NoForm 4
Craver JosiahPFO & PAOApr 10Apr 14A · derivative80,000$29.89$2,391,20080,000NoForm 4
Donenberg Phillip B.Feb 13Feb 17A · derivative1,900$9.09$17,2711,900NoForm 4
Peyer JamesDec 9, 2025Dec 10, 2025S2,666$7.95Sale −$21,195155,588NoForm 4
Peyer JamesDec 9, 2025Dec 10, 2025M395$6.40$2,528155,983NoForm 4
Peyer JamesDec 9, 2025Dec 10, 2025S395$8.04Sale −$3,176155,588NoForm 4
Peyer JamesDec 9, 2025Dec 10, 2025S446$7.92Sale −$3,532155,142NoForm 4
Peyer JamesDec 9, 2025Dec 10, 2025M · derivative395$6.40$2,528not reportedNoForm 4
Cambrian BioPharma IncDec 9, 2025Dec 10, 2025S3,105$8.59Sale −$26,672158,254NoForm 4
Cambrian BioPharma IncDec 9, 2025Dec 10, 2025S2,666$7.95Sale −$21,195155,588NoForm 4
Cambrian BioPharma IncDec 9, 2025Dec 10, 2025M395$6.40$2,528155,983NoForm 4
Cambrian BioPharma IncDec 9, 2025Dec 10, 2025S395$8.04Sale −$3,176155,588NoForm 4
Cambrian BioPharma IncDec 9, 2025Dec 10, 2025S446$7.92Sale −$3,532155,142NoForm 4
Cambrian BioPharma IncDec 9, 2025Dec 10, 2025M · derivative395$6.40$2,528not reportedNoForm 4
Peyer JamesDec 8, 2025Dec 10, 2025S3,105$8.59Sale −$26,672158,254NoForm 4
Peyer JamesDec 5, 2025Dec 8, 2025S14,508$11.40Sale −$165,391163,146NoForm 4
Peyer JamesDec 5, 2025Dec 8, 2025S1,745$12.29Sale −$21,446161,401NoForm 4
Peyer JamesDec 5, 2025Dec 8, 2025S42$13.16Sale −$553161,359NoForm 4
Cambrian BioPharma IncDec 5, 2025Dec 8, 2025S14,508$11.40Sale −$165,391163,146NoForm 4
Cambrian BioPharma IncDec 5, 2025Dec 8, 2025S1,745$12.29Sale −$21,446161,401NoForm 4
Cambrian BioPharma IncDec 5, 2025Dec 8, 2025S42$13.16Sale −$553161,359NoForm 4
Peyer JamesDec 4, 2025Dec 8, 2025S5,000$9.06Sale −$45,300177,654NoForm 4
Cambrian BioPharma IncDec 4, 2025Dec 8, 2025S5,000$9.06Sale −$45,300177,654NoForm 4
Ringo William RMay 21, 2025May 23, 2025A · derivative19,000$0.32$6,08019,000NoForm 4
Holmen BobMay 21, 2025May 23, 2025A · derivative19,000$0.32$6,08019,000NoForm 4
Humer KristianMay 21, 2025May 23, 2025A · derivative19,000$0.32$6,08019,000NoForm 4
Peyer JamesMay 21, 2025May 23, 2025A · derivative19,000$0.32$6,08019,000NoForm 4
Ricks Thomas GMay 21, 2025May 23, 2025A · derivative19,000$0.32$6,08019,000NoForm 4
Cambrian BioPharma IncMay 21, 2025May 23, 2025A · derivative19,000$0.32$6,08019,000NoForm 4
van der Horst EdwardCHIEF SCIENTIFIC OFFICERFeb 19, 2025Feb 26, 2025F2,276$0.48$1,09259,794NoForm 4
Celebi JohnPRESIDENT AND CEOFeb 19, 2025Feb 26, 2025F5,558$0.48$2,668105,862NoForm 4
van der Horst EdwardCHIEF SCIENTIFIC OFFICERFeb 14, 2025Feb 14, 2025A · derivative110,000$0.48$52,800110,000NoForm 4
Celebi JohnPRESIDENT AND CEOFeb 14, 2025Feb 14, 2025A · derivative360,000$0.48$172,800360,000NoForm 4
Craver JosiahPrincipal Financial OfficerFeb 14, 2025Feb 14, 2025A · derivative50,000$0.48$24,00050,000NoForm 4
Krebs StephanieChief Business OfficerFeb 14, 2025Feb 14, 2025A · derivative120,000$0.48$57,600120,000NoForm 4
Celebi JohnPRESIDENT AND CEODec 20, 2024Dec 23, 2024A · derivative355,000$0.45$159,750355,000NoForm 4
Craver JosiahPrincipal Financial OfficerDec 20, 2024Dec 23, 2024A · derivative100,000$0.45$45,000100,000NoForm 4
van der Horst EdwardCHIEF SCIENTIFIC OFFICERDec 20, 2024Dec 23, 2024A · derivative100,000$0.45$45,000100,000NoForm 4
Krebs StephanieChief Business OfficerDec 20, 2024Dec 23, 2024A · derivative120,000$0.45$54,000120,000NoForm 4
Vojta DeneenJun 11, 2024Jun 13, 2024A · derivative19,000$0.71$13,49019,000NoForm 4
Ricks Thomas GJun 11, 2024Jun 13, 2024A · derivative19,000$0.71$13,49019,000NoForm 4
Ringo William RJun 11, 2024Jun 13, 2024A · derivative19,000$0.71$13,49019,000NoForm 4
Humer KristianJun 11, 2024Jun 13, 2024A · derivative19,000$0.71$13,49019,000NoForm 4
English JessieJun 11, 2024Jun 13, 2024A · derivative19,000$0.71$13,49019,000NoForm 4
Holmen BobJun 11, 2024Jun 13, 2024A · derivative19,000$0.71$13,49019,000NoForm 4
Peyer JamesJun 11, 2024Jun 13, 2024A · derivative19,000$0.71$13,49019,000NoForm 4
Cambrian BioPharma IncJun 11, 2024Jun 13, 2024A · derivative19,000$0.71$13,49019,000NoForm 4
Colgan ErinCHIEF FINANCIAL OFFICERFeb 15, 2024Feb 16, 2024F3,627$0.79$2,86567,462NoForm 4
Colgan ErinCHIEF FINANCIAL OFFICERFeb 15, 2024Feb 16, 2024A · derivative125,000$0.79$98,750125,000NoForm 4
Colgan ErinCHIEF FINANCIAL OFFICERFeb 15, 2024Feb 16, 2024A · derivative94,128$0.79$74,36194,128NoForm 4
Celebi JohnPRESIDENT AND CEOFeb 15, 2024Feb 16, 2024F5,891$0.79$4,654105,420NoForm 4
Celebi JohnPRESIDENT AND CEOFeb 15, 2024Feb 16, 2024A · derivative315,000$0.79$248,850315,000NoForm 4
Celebi JohnPRESIDENT AND CEOFeb 15, 2024Feb 16, 2024A · derivative165,889$0.79$131,052165,889NoForm 4
van der Horst EdwardCHIEF SCIENTIFIC OFFICERFeb 15, 2024Feb 16, 2024F2,843$0.79$2,24656,070NoForm 4
van der Horst EdwardCHIEF SCIENTIFIC OFFICERFeb 15, 2024Feb 16, 2024A · derivative125,000$0.79$98,750125,000NoForm 4
van der Horst EdwardCHIEF SCIENTIFIC OFFICERFeb 15, 2024Feb 16, 2024A · derivative90,102$0.79$71,18190,102NoForm 4
Krebs StephanieChief Business OfficerNov 1, 2023Nov 2, 2023A · derivative125,000$0.82$102,500125,000NoForm 4